pyridostigmine reversal
Selected indexed studies
- Neostigmine. (, 2006) [PMID:30000438]
- Association of sugammadex, neostigmine, or pyridostigmine for reversal of neuromuscular block with postoperative bradycardia: a multicentre, retrospective observational study. (Br J Anaesth, 2025) [PMID:40480915]
- Neuromuscular blockade reversal with sugammadex versus pyridostigmine/glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility. (Korean J Anesthesiol, 2020) [PMID:31636242]
_Worker-drafted node — pending editorial review._
Connections
pyridostigmine reversal is a side effect of
Sources
- Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review. (2019) pubmed
- Cholinergic Medications. (2026) pubmed
- Neostigmine. (2006) pubmed
- Association of sugammadex, neostigmine, or pyridostigmine for reversal of neuromuscular block with postoperative bradycardia: a multicentre, retrospective observational study. (2025) pubmed
- Neuromuscular blockade reversal with sugammadex versus pyridostigmine/glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility. (2020) pubmed
- Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study. (2020) pubmed
- N-[(11)C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium. (2004) pubmed
- Pyridostigmine for reversal of severe sequelae from botulinum toxin injection. (2014) pubmed
- Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study: Retraction. (2020) pubmed
- Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children. (2018) pubmed